Table
3: Cases with no
recurrence in the liver for more than 3years after initial treatment for
liver metastases
|
Case No. |
ER* |
PgR† |
HER‡ |
Location
of Liver metastases |
Ope. Method |
Adjuvant therapy |
Exrahepatic metastases after Liver operation |
|
1 |
+ |
+ |
|
HR¶ + MCN§ |
C** + E†† |
- |
|
|
2 |
- |
|
MCN |
none |
- |
||
|
3 |
- |
- |
|
HR |
E |
LN#, ovary |
|
|
4 |
2+ |
|
HR + MCN |
C + T‡‡ |
bone, LN |
||
|
5 |
+ |
+ |
1+ |
|
MCN |
C + E |
bone |
|
6 |
+ |
+ |
|
HR |
C + E |
lung, bone LN, ovary |
|
|
7 |
+ |
+ |
- |
|
HR |
E |
- |
*estrogen-receptor; †progesterone-receptor; ‡human epidermal
growth factor receptor; **chemotherapy; ††endocrine therapy; ‡‡Trastuzumab, §microwave coagule-necrotic
therapy; ¶hepatic resection; #lymph node